ammonia levels were significantly increased in BDL rats at day 28 compared to non-BDL control rats.
1 6
However, when comparing the two BDL groups, the plasma levels of the polymersome and the citric 2 1 7 acid control group were not significantly different ( Figure 4C ). We hypothesize that the increase in 2 1 8 stool hydration provided by the laxative was insufficient to prevent the destabilization of the 2 1 9 polymersomes in the intestinal environment as they lose two thirds of their ammonia capture capacity 2 2 0 in a dietary fiber hydrogel with a water content of 80% (m/m, i.e., fiber content 20% (m/m), Figure 3A ).
1
The polymersome stability could potentially be improved by further increasing the laxative dose. However, excessive fluid and electrolyte losses could limit such a dose elevation. The present study shows that vesicles, which appear stable under highly challenging in vitro conditions, may still be 2 2 4 destabilized in the GI tract, especially as the chyme becomes dehydrated. Therefore, more in-depth 2 2 5 studies are warranted to investigate the stability of vesicular carriers in the GI tract, especially when 2 2 6 they are used to deliver labile drugs such as insulin via the oral route.
[16] Sprague-Dawley rats 21 days after BDL surgery gavaged with water (5 mL/kg), PEG (3350) (PEG, 1 2 3 0 g/kg), or sodium picosulfate (25 mg/kg) for at least two days (n = 3-19 stool samples) (A). Study plan: 2 3 1 three weeks after BDL surgery, two groups of cirrhotic rats (n = 16-17 per group) received sodium PS-b- PEO(2000) polymer/kg; PS fragment length: 2800-5500 g/mol) or citric acid solution alone (twice 2 3 4 daily 0.24 g citric acid/kg) by gavage for one week. A group of age-matched healthy control rats (n = 2 3 5 6) received citric acid solution (twice daily 0.24 g/kg) by gavage for one week (B). Plasma ammonia 2 3 6 levels in BDL rats at 21 days (saphenous vein) and at sacrifice at 28 days (cardiac puncture) after BDL 2 3 7 surgery (polymersome group n = 16, citric acid group n = 17) and in age-matched healthy controls (non-BDL control group n = 6, C). All results as means ± SD. *p < 0.05, **p < 0.01, and ***p < 0.001. Notwithstanding, the transmembrane pH-gradient polymersomes may constitute a valuable diagnostic 2 4 3 tool for HE and UCD, since adequate and affordable assays for the quantification of ammonia in determination of the extravesicular ammonia concentration ( Figure 1B) . As for the oral application, 2 4 7 very high selectivity and stability of the vesicles are required for the diagnostic application. HPTS was high hydrophilicity (three negative charges) which hinders its leakage. In addition, the isosbestic 2 5 0 excitation wavelength allows for a correction of slight differences in dye concentration. physiologically relevant range of 12.5 to 800 µM ( Figure 5A ). The concentrations of the calibration 2 5 3 standards could be back-calculated with high accuracy and precision both below (non- Table   2 6 0 S3). Under the investigated conditions, the lower limit of quantification was as low as 27 µM. Both a 2 6 1 low and a high volume fraction of the ammonia standards showed a low time dependence of the 2 6 2 fluorescence intensity ratio after 10 min at room temperature ( Figure 5B ) which points to the 2 6 3 usefulness of the assay for high throughput screenings. Furthermore, PS-b-PEO polymersomes 2 6 4 remained sensitive to ammonia after five months of storage in an isotonic phosphate buffer at pH 7.4 2 6 5 and 4°C (Supplementary Figure S9) , highlighting the stability of the transmembrane pH gradient over 2 6 6 time. differences were observed between 10 min and 30 min for a given ammonia concentration and volume 2 7 3 fraction of standard. Ammonia concentrations measured using the polymersome assay upon co- endogenous compounds (levofloxacin, propranolol, glycine, alanine, dopamine, each at 500 µM) (C). No significant differences were observed between the ammonia concentrations determined in the absence and presence of the tested potentially interfering substances. Inner phase: isotonic citrate buffer 5 mM at pH 5.5; outer phase: isotonic phosphate buffer 50 mM at pH 7.4. HPTS concentration To assess the selectivity of the polymersome assay, PS-b-PEO polymersomes were co-incubated with 2 8 5 amine-containing weakly basic substances (Supplementary Table S4 ). The di-and tri-methylated
analogs of ammonia (dimethylamine, DMA, and trimethylamine, TMA, respectively) were chosen 2 8 7
because of their structural similarity to ammonia and their physiological relevance. [50, 51] Even at 2 8 8
concentrations exceeding physiological serum concentrations by more than 25-fold, [50, 51] DMA and 2 8 9
TMA did not significantly influence the measured ammonia concentration ( Figure 5C ). Moreover, a 2 9 0 mixture of drugs and metabolites (levofloxacin, propranolol, glycine, alanine, dopamine, each in five-
fold molar excess over ammonia) did not interfere with the ammonia assay. PS-b-PEO polymersomes 2 9 2 therefore selectively sequestered ammonia in the presence of weakly basic molecules that were
shown to interfere with ammonia uptake in liposomes. [15, 52] The highly hydrophobic, rigid membrane of
PS-b-PEO polymersomes probably hinders the diffusion of bulkier and more hydrophilic substrates
than ammonia. To evaluate the polymersome assay in plasma of healthy and BDL rats, the ammonia concentrations determined by the polymersome assay, the GLDH-based test, and the PocketChem BA were 2 9 9
compared. In healthy rat plasma, the three tests performed similarly except for two hemolyzed assay. [11] In plasma of BDL rats, which exhibit typical pathological changes in biochemical laboratory
parameters of liver cirrhosis (Supplementary Table S5 ), [11, 14] an interference in the polymersome assay sample volume fraction to 17% (i.e., diluting the bilirubin) yielded similar results compared with the 3 0 7
GLDH assay ( Figure 6B ). Alternatively, this interference might be circumvented by the replacement of
HPTS with a pH-sensitive near-infrared dye which could further enable ammonia sensing in whole 3 0 9
blood. In accordance with the literature, the PocketChem BA yielded significantly lower ammonia 3 1 0 levels than the GLDH assay.
[12] nm) using pH-dependent λ ex (413 nm) normalized to emission at the same λ em using the isosbestic λ (455 nm). All results as mean ± SD (n = 3-10). *p < 0.05, **p < 0.01, and ***p < 0.001. Interestingly, the polymersome-based ammonia assay was not limited to the determination of the sample volume fraction ( Figure 7A ). It was also capable of discriminating ammonia-spiked
intestinal fluid samples ( Figure 7B ), which could be of interest in the establishment of a high-
throughput screening for urease inhibitors. Furthermore, co-incubating the polymersomes with L-
phenylalanine ammonia-lyase, which converts L-phenylalanine to ammonia and trans-cinnamic acid,
enabled the quantification of phenylalanine (Supplementary Figure S12) . The plasma levels of this hydroxylase deficiency.
[54] polymersome-and GLDH-based ammonia assays in human saliva, semen, urine, and sweat (A). No 3 3 5 statistically significant differences were observed between the two ammonia assays. Baseline-
corrected fluorescence emission ratio of HPTS-containing polymersomes in rat caecum fluid spiked
with ammonium chloride (B). PS fragment length: 2800 (A), 4100 (B). Inner phase: isotonic citrate
buffer 5 mM at pH 5.5, outer phase: isotonic phosphate buffer 50 mM at pH 7.4. HPTS concentration vesicular delivery systems in the GI tract. Polymer Materials (Dorval, QC, Canada; Supplementary Aldrich Chemie, Buchs, Switzerland) was converted to an ATRP macroinitiator by reacting it with 2-3 5 7
bromopropionyl bromide (Sigma-Aldrich Chemie) in dry tetrahydrofuran (Acros Organics, New Jersey, several cycles to remove oxygen. In a separate flask, styrene (100 mmol, 11.5 mL, Sigma-Aldrich
Chemie) was deoxygenated by argon bubbling for 0.5 h, and then loaded in the Schlenk flask. The Figure S13).
For the molecular weight and dispersity (Đ) determination of the PS-b-PEO diblock co-polymers 3 7 1 (Supplementary Table S7 ), the polymers were dissolved in THF at 2 mg/mL and characterized by gel-
permeation chromatography with the same organic solvent (0.5 mL/min) as mobile phase equipped
with two ViscoGEL columns (GMHHR-M, poly(styrene-co-divinylbenzene)) at 35°C and coupled to a Viscotek, Malvern Panalytical, Malvern, UK) using poly(methylmethacrylate) standards (2500 -89300, PSS Polymer Standards Service, Mainz, Germany). Canada) and PS-b-PEO polymersomes were produced using an oil-in-water (o/w) emulsification a rotary evaporator for at least 5 min at 40°C at 70 kPa.
In the scaled-up method, 1.84 g PS-b-PEO polymer (diblock copolymers from Supplementary Table   3  9  1 S7; PS-b-PEO polymer batches with different PS fragment length were never pooled prior to 3 9 2 polymersome preparation) were dissolved in 1.84 mL dichloromethane. The polymer solution was an ice bath using the following parameters: initial amplitude 50 (6 mm sonotrode, Fisher Scientific
Model 705 Sonic Dismembrator) during the addition of the oil phase (approx. 1 min) and subsequent sonication at amplitude 60 for another 3 min. The organic solvent was evaporated using a rotary 3 9 7
evaporator for at least 10 min at 40 °C at 60 kPa. The polymersome batches were subsequently 3 9 8
pooled. The concentration of dichloromethane in the pooled polymersome batches was further The fluorescent polymersomes were purified using MidiTrap G-25 columns (GE Healthcare Europe, and 800 µL of buffer solution were added to the column. The purified fluorescent polymersomes were
eluted with 600 µL of buffer and stored at 4 °C protected from light. 
Concentration of polymer in the polymersome dispersions
The polymer concentration of PS-b-PEO was determined by spectrophotometry. The dispersion was The polymer concentration of PBD-b-PEO in the polymersome dispersion was determined by gel- dimethylformamide and analyzed using gel-permeation chromatography with the same organic solvent 4 2 8 (0.5 mL/min) as mobile phase using the same columns and detector as described above. The area
under the curve of the polymer peak was used to calculate the polymer concentration after calibration
with a PBD-b-PEO standard curve.
The concentration of dye in the fluorescent polymersome dispersion was determined by fluorescence fluorescence emission of the supernatant was determined at 510 nm (excitation wavelength 413 nm).
3 5
The HPTS concentration in the polymersome dispersion was calculated with a HPTS standard curve The dichloromethane content was determined using headspace gas chromatography coupled to a polymersomes, liposomes, and microparticles were determined using the Mastersizer2000 laser SEM (Leo-1530, Zeiss, Oberkochen, Germany) at -120°C in accordance with the literature.
[56] Liposomes composed of (i) 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC, LIPOID,
Ludwigshafen, Germany) or 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC, LIPOID), (ii) The transmembrane pH-gradient was generated in side-by-side diffusion cells (PermeGear Inc.,
Hellertown, PA) by dilution in alkaline phosphate buffer (final phosphate concentration 50 mM, pH 6.8,
osmolality 300 mOsmol/kg) in the absence and presence of the bile salts sodium cholate (SC), sodium added to the potassium phosphate buffer 50 mM (final potassium concentration 250 mM).
The dual-chamber system was separated by a track etch polycarbonate membrane (pore size = 100 4 9 1 nm, Sterlitech, Kent, WA), physically isolating the vesicles on one side. At 37°C, the lipid or polymer and the ammonia concentrations within the diffusion cells were 1.75 mg/mL and 1.5 mM, respectively.
9 3
At the allotted time points, aliquots were taken from the vesicle-free compartment. The ammonia 4 9 4 22 concentration of the samples was determined by the Berthelot reaction.
[13] The ammonia uptake was 4 9 5 quantified using equation 1 with the total mass of sequestrant being the total mass of lipid or polymer:
( 1 ) To evaluate their ammonia uptake, zeolite (Sigma Aldrich Chemie), poly(methacrylic acid) (PMAA,
Lewatit CNP-105, Sigma Aldrich Chemie), mesostructured silica (Sigma Aldrich Chemie), or activated The cation competition experiments with zeolite microparticles (20 mg/mL) were conducted similarly
with a modified buffer (HEPES 100 mM at pH 7.0 supplemented with 50 to 2000 mM sodium,
potassium, or calcium) and an incubation time of 30 min at 37°C. HTPS/DPX-containing polymersomes: 50 µM and 30 µM, respectively) containing 1.5 mM ammonia filtered with a 0.2 µm syringe filter.
For the non-fluorescent polymersomes, the ammonia concentration of the filtered solution was extraction from the hydrogel matrix, the fluorescence intensity of DPX/HPTS-containing polymersomes polymersome-based ammonia assay experiments.
The fluorescence excitation spectra of HPTS at 100 µM in isotonic citric acid solution 5.5 mM (pH 2.0-
5.7) or isotonic phosphate buffer 50 mM (pH 6.8-11.0) was determined at a fixed emission wavelength The samples, standards, or blank were co-incubated with polymersomes in isotonic phosphate buffer isosbestic excitation wavelength). The fluorescence emission ratio of the ammonia standards was concentration. The precision was defined as coefficient of variation (i.e., standard deviation normalized 5 4 8
to mean). The lower limit of quantification (LOQ) was determined using equation 2 which relates to the precision (CV below 20%) was determined (50 µM). The measurements below this value were set as 6 5 5
25 µM in accordance with the literature.
[14]
6 5 6
To measure ammonia levels with the PocketChem BA, 20 µL of sample was applied onto the strip 6 5 7
(Ammonia Test Kit II, Arkray) and measured in mode F6 according to the manufacturer's instructions.
5 8
To establish the ammonia standard curve, the ammonia standard from the Randox enzymatic 6 5 9
ammonia assay (298 µM) was taken and diluted in water. The standards were measured in mode F6 TMA standards in phosphate buffer at pH 8.0 were prepared, applied on the strip, and measured after 6 6 2 1 min incubation. In the ammonia quantification using the Berthelot reaction, the ammonia-containing sample was 6 6 4 added to equivolumetric amounts of alkaline sodium hypochlorite and phenol nitroprusside solution 6 6 5
